한국학술지인용색인(NRF)
권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
국회도서관 홈으로
정보검색
소장정보 검색
결과 내 검색
동의어 포함
저자 검색
- 검색종류
| 대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
|---|---|---|---|---|---|---|---|---|---|
| 연구/단체명을 입력해주세요. | |||||||||
관련 키워드 검색
- 대표어
- 외국어
|
|
|
|
|
|
주제별 검색
* 주제를 선택하시면 검색 상세로 이동합니다.
초록보기
Immunoassays are powerful qualitative and quantitative analytical techniques. Since the first description of an immunoassay method in 1959, advances have been made in assay designs and analytical characteristics, opening the door for their widespread implementation in clinical laboratories. Clinical endocrinology is closely linked to laboratory medicine because hormone quantification is important for the diagnosis, treatment, and prognosis of endocrine disorders. Several interferences in immunoassays have been identified through the years; although some are no longer encountered in daily practice, cross-reaction, heterophile antibodies, biotin, and anti-analyte antibodies still cause problems. Newer interferences are also emerging with the development of new therapies. The interfering substance may be exogenous (e.g., a drug or substance absorbed by the patient) or endogenous (e.g., antibodies produced by the patient), and the bias caused by interference can be positive or negative. The consequences of interference can be deleterious when clinicians consider erroneous results to establish a diagnosis, leading to unnecessary explorations or inappropriate treatments. Clinical laboratories and manufacturers continue to investigate methods for the detection, elimination, and prevention of interferences. However, no system is completely devoid of such incidents. In this review, we focus on the analytical interferences encountered in daily practice and possible solutions for their detection or elimination.
권호기사
참고문헌 (196건) : 자료제공( 네이버학술정보 )
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Wu AH. A selected history and future of immunoassay development and applications in clinical chemistry. Clin Chim Acta 2006;369:119-24. | 미소장 |
| 2 | Sturgeon CM and Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem 2011;48:418-32. | 미소장 |
| 3 | Köhler G and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7. | 미소장 |
| 4 | Tate J and Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105-20. | 미소장 |
| 5 | Sturgeon CM. External quality assessment of hormone determinations. Best Pract Res Clin Endocrinol Metab 2013;27:803-22. | 미소장 |
| 6 | Darwish IA. Immunoassay methods and their applications in pharmaceutical analysis: basic methodology and recent advances. Int J Biomed Sci 2006;2:217-35. | 미소장 |
| 7 | Caruso B, Bovo C, Guidi GC. Causes of preanalytical interferences on laboratory immunoassays–A critical review. EJIFCC 2020;31:70-84. | 미소장 |
| 8 | Gnocchi D and Bruscalupi G. Circadian rhythms and hormonal homeostasis: pathophysiological implications. Biology (Basel) 2017;6:10. | 미소장 |
| 9 | Long N, Nguyen L, Stevermer J. PURLS: It’s time to reconsider early-morning testosterone tests. J Fam Pract 2015;64:418-9. | 미소장 |
| 10 | Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36:704-21. | 미소장 |
| 11 | Owen LJ, Monaghan PJ, Armstrong A, Keevil BG, Higham C, Salih Z, et al. Oestradiol measurement during fulvestrant treatment for breast cancer. Br J Cancer 2019;120:404-6. | 미소장 |
| 12 | Mandic S, Kratzsch J, Mandic D, Debeljak Z, Lukic I, Horvat V, et al. Falsely elevated serum oestradiol due to exemestane therapy. Ann Clin Biochem 2017;54:402-5. | 미소장 |
| 13 | Valdes R and Jortani SA. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem 2002;48:405-6. | 미소장 |
| 14 | Lopez AG, Fraissinet F, Lefebvre H, Brunel V, Ziegler F. Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma. Ann Endocrinol (Paris) 2019;80:250-8. | 미소장 |
| 15 | Groenestege WM, Bui HN, ten Kate J, Menheere PP, Oosterhuis WP, Vader HL, et al. Accuracy of first and second generation testosterone assays and improvement through sample extraction. Clin Chem 2012;58:1154-6. | 미소장 |
| 16 | Benton SC, Nuttall M, Nardo L, Laing I. Measured dehydroepiandrosterone sulfate positively influences testosterone measurement in unextracted female serum: comparison of 2 immunoassays with testosterone measured by LC-MS. Clin Chem 2011;57:1074-5. | 미소장 |
| 17 | Honour JW. Steroid assays in paediatric endocrinology. J Clin Res Pediatr Endocrinol 2010;2:1-16. | 미소장 |
| 18 | Paisley AN, Hayden K, Ellis A, Anderson J, Wieringa G, Trainer PJ. Pegvisomant interference in GH assays results in underestimation of GH levels. Eur J Endocrinol 2007;156:315-9. | 미소장 |
| 19 | Manolopoulou J, Alami Y, Petersenn S, Schopohl J, Wu Z, Strasburger CJ, et al. Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin Chem 2012;58:1446-56. | 미소장 |
| 20 | RaffH and Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing’s syndrome. Clin Chem 1989;35:596-600. | 미소장 |
| 21 | Woeber KA, White A, Kurtz TW. Recurrent pituitary macroadenoma with increased plasma ACTH precursors that cross-react in a commonly used ACTH immunoassay. Endocr Pract 2014;20:94-6. | 미소장 |
| 22 | Parfitt C, Church D, Armston A, Couchman L, Evans C, Wark G, et al. Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues. Clin Biochem 2015;48:1354-7. | 미소장 |
| 23 | Dayaldasani A, Rodríguez Espinosa M, Ocón Sánchez P, Pérez Valero V. Cross-reactivity of insulin analogues with three insulin assays. Ann Clin Biochem 2015;52:312-8. | 미소장 |
| 24 | Giurgea I, Ulinski T, Touati G, Sempoux C, Mochel F, Brunelle F, et al. Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy. Pediatrics 2005;116:e145-8. | 미소장 |
| 25 | Drees JC, Stone JA, Reamer CR, Arboleda VE, Huang K, Hrynkow J, et al. Falsely undetectable TSH in a cohort of South Asian euthyroid patients. J Clin Endocrinol Metab 2014;99:1171-9. | 미소장 |
| 26 | Ward G, Simpson A, Boscato L, Hickman PE. The investigation of interferences in immunoassay. Clin Biochem 2017;50:1306-11. | 미소장 |
| 27 | Haddad RA, Giacherio D, Barkan AL. Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clin Diabetes Endocrinol 2019;5:12. | 미소장 |
| 28 | Frieze TW, Mong DP, Koops MK. “Hook effect” in prolactinomas: case report and review of literature. Endocr Pract 2002;8:296-303. | 미소장 |
| 29 | Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab 2013;27:647-61. | 미소장 |
| 30 | Ismail AA. Identifying and reducing potentially wrong immunoassay results even when plausible and “not-unreasonable”. Adv Clin Chem 2014;66:241-94. | 미소장 |
| 31 | Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 2018;39:830-50. | 미소장 |
| 32 | Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-56. | 미소장 |
| 33 | Bergman D, Larsson A, Hansson-Hamlin H, Åhlén E, Holst BS. Characterization of canine anti-mouse antibodies highlights that multiple strategies are needed to combat immunoassay interference. Sci Rep 2019:9:14521. | 미소장 |
| 34 | Boscato LM and Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27-33. | 미소장 |
| 35 | Hattori N, Ishihara T, Shimatsu A. Variability in the detection of macro TSH in different immunoassay systems. Eur J Endocrinol 2016;174:9-15. | 미소장 |
| 36 | Giovanella L and Ghelfo A. Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma. Clin Chem 2007;53:1871-2. | 미소장 |
| 37 | Ramaeker D, Brannian J, Egland K, McCaul K, Hansen K. When is elevated testosterone not testosterone? When it is an immunoassay interfering antibody. Fertil Steril 2008;90:886-8. | 미소장 |
| 38 | Brugts MP, Luermans JG, Lentjes EG, Van Trooyen-van VrouwerffNJ, Van der Horst FA, Slee PH, et al. Heterophilic antibodies may be a cause of falsely low total IGF1 levels. Eur J Endocrinol 2009;161:561-5. | 미소장 |
| 39 | Saleem M, Lewis JG, Florkowski CM, Mulligan GP, George PM, Hale P. A patient with pseudo-Addison’s disease and falsely elevated thyroxine due to interference in serum cortisol and free thyroxine immunoassays by two different mechanisms. Ann Clin Biochem 2009;46:172-5. | 미소장 |
| 40 | Gulbahar O, Konca Degertekin C, Akturk M, Yalcin MM, Kalan I, Atikeler GF, et al. A case with immunoassay interferences in the measurement of multiple hormones. J Clin Endocrinol Metab 2015;100:2147-53. | 미소장 |
| 41 | García-González E, Aramendía M, Álvarez-Ballano D, Trincado P, Rello L. Serum sample containing endogenous antibodies interfering with multiple hormone immunoassays. Laboratory strategies to detect interference. Pract Lab Med 2015;4:1-10. | 미소장 |
| 42 | Oei AL, Sweep FC, Massuger LF, Olthaar AJ, Thomas CM. Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody. Gynecol Oncol 2008;109:199-202. | 미소장 |
| 43 | Kazmierczak SC, Catrou PG, Briley KP. Transient nature of interference effects from heterophile antibodies: examples of interference with cardiac marker measurements. Clin Chem Lab Med 2000;38:33-9. | 미소장 |
| 44 | Berglund Land Holmberg NG. Heterophilic antibodies against rabbit serum causing falsely elevated gonadotropin levels. Acta Obstet Gynecol Scand 1989;68:377-8. | 미소장 |
| 45 | Klee GG. Interferences in hormone immunoassays. Clin Lab Med 2004;24:1-18. | 미소장 |
| 46 | Ismail AA. On the diagnosis of subclinical hypothyroidism. Br J Gen Pract 2007;57:1000-1. | 미소장 |
| 47 | Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 2020;27:1. | 미소장 |
| 48 | Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, et al. French endocrine society guidance on endocrine side effects of immunotherapy. Endocr Relat Cancer 2019;26:G1-18. | 미소장 |
| 49 | Lahlou N and Raverot V. Expert opinions on endocrine toxicity induced by new anticancer therapies: precautions to be taken in performing and interpreting hormonal assays under immunotherapy. Ann Endocrinol (Paris) 2018;79:550-4. | 미소장 |
| 50 | Koshida S, Asanuma K, Kuribayashi K, Goto M, Tsuji N, Kobayashi D, et al. Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations. Clin Chim Acta 2010;411:391-4. | 미소장 |
| 51 | Emerson JF and Lai KKY. Endogenous antibody interferences in immunoassays. Lab Med 2013;44:69-73. | 미소장 |
| 52 | Jonklaas J. TSH-free thyroxine discordance in an athyreotic patient during ipiluminab and nivoluminab therapy. AACE Clin Case Rep 2016;2:e296-301. | 미소장 |
| 53 | Kim D, Hong N, Cho Y, Lee SG, Rhee Y. Heterophile antibody interference associated with natural killer cell therapy. Endocr J 2020;67:1187-92. | 미소장 |
| 54 | Holm BE, Sandhu N, Tronstrøm J, Lydolph M, Trier NH, Houen G. Species cross-reactivity of rheumatoid factors and implications for immunoassays. Scand J Clin Lab Invest 2015;75:51-63. | 미소장 |
| 55 | Astarita G, Gutiérrez S, Kogovsek N, Mormandi E, Otero P, Calabrese C, et al. False positive in the measurement of thyroglobulin induced by rheumatoid factor. Clin Chim Acta 2015;447:43-6. | 미소장 |
| 56 | Mongolu S, Armston AE, Mozley E, Nasruddin A. Heterophilic antibody interference affecting multiple hormone assays: is it due to rheumatoid factor? Scand J Clin Lab Invest 2016;76:240-2. | 미소장 |
| 57 | Cheng X, Guo X, Chai X, Hu Y, Lian X, Zhang G. Heterophilic antibody interference with TSH measurement on different immunoassay platforms. Clin Chim Acta 2021;512:63-5. | 미소장 |
| 58 | Laudes M, Frohnert J, Ivanova K, Wandinger KP. PTH immunoassay interference due to human anti-mouse antibodies in a subject with obesity with normal parathyroid function. J Clin Endocrinol Metab 2019;104:5840-2. | 미소장 |
| 59 | Fruzzetti F, Palla G, Sbrana A, Simoncini T, Sessa MR. Anti-goat antibodies as a rare cause of high gonadotropin levels during menopausal transition. Gynecol Endocrinol 2020;36:938-40. | 미소장 |
| 60 | Aliberti L, Gagliardi I, Dorizzi RM, Pizzicotti S, Bondanelli M, Zatelli MC, et al. Hypeprolactinemia: still an insidious diagnosis. Endocrine 2021;72:928-31. | 미소장 |
| 61 | Hattori N, Aisaka K, Shimatsu A. A possible cause of the variable detectability of macroprolactin by different immunoassay systems. Clin Chem Lab Med 2016;54:603-8. | 미소장 |
| 62 | Overgaard M and Pedersen SM. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Clin Chem Lab Med 2017;55:1744-53. | 미소장 |
| 63 | Fahie-Wilson M and Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013;27:725-42. | 미소장 |
| 64 | Hattori N, Ikekubo K, Nakaya Y, Kitagawa K, Inagaki C. Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinemia due to anti-PRL autoantibodies. J Clin Endocrinol Metab 2005;90:3036-44. | 미소장 |
| 65 | Richa V, Rahul G, Sarika A. Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice. J Reprod Infertil 2010;11:161-7. | 미소장 |
| 66 | Fahie-Wilson M and Halsall D. Polyethylene glycol precipitation: proceed with care. Ann Clin Biochem 2008;45:233-5. | 미소장 |
| 67 | Barth JH, Lippiatt CM, Gibbons SG, Desborough RA. Observational studies on macroprolactin in a routine clinical laboratory. Clin Chem Lab Med 2018;56:1259-62. | 미소장 |
| 68 | Webster R, Fahie-Wilson M, Barker P, Chatterjee VK, Halsall DJ. Immunoglobulin interference in serum follicle-stimulating hormone assays: autoimmune and heterophilic antibody interference. Ann Clin Biochem 2010;47:386-9. | 미소장 |
| 69 | Ohba K, Maekawa M, Iwahara K, Suzuki Y, Matsushita A, Sasaki S, et al. Abnormal thyroid hormone response to TRH in a case of macro-TSH and the cut-offvalue for screening cases of inappropriate TSH elevation. Endocr J 2020;67:125-30. | 미소장 |
| 70 | Loh TP, Kao SL, Halsall DJ, Toh SA, Chan E, Ho SC, et al. Macro-thyrotropin: a case report and review of literature. J Clin Endocrinol Metab 2012;97:1823-8. | 미소장 |
| 71 | Rix M, Laurberg P, Porzig C, Kristensen SR. Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex. Acta Paediatr 2011;100:e135-7. | 미소장 |
| 72 | Halsall DJ, Fahie-Wilson MN, Hall SK, Barker P, Anderson J, Gama R, et al. Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. Clin Chem 2006;52:1968-9; author reply 1969-70. | 미소장 |
| 73 | Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133. | 미소장 |
| 74 | Spencer C, LoPresti J, Fatemi S. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Curr Opin Endocrinol Diabetes Obes 2014;21:394-404. | 미소장 |
| 75 | Giovanella L, Feldt-Rasmussen U, Verburg FA, Grebe SK, Plebani M, Clark PM. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges. Clin Chem Lab Med 2015;53:1301-14. | 미소장 |
| 76 | Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore) 2009;88:141-53. | 미소장 |
| 77 | Ismail AA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med 2016;54:1715-24. | 미소장 |
| 78 | Lamy PJ, Sault C, Renard E. High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report. Ann Biol Clin (Paris) 2016;74:490-4. | 미소장 |
| 79 | Piketty ML, Brabant S, Souberbielle JC, Maruani G, Audrain C, Rothenbuhler A, et al. FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference. Clin Chem Lab Med 2020;58:e267-9. | 미소장 |
| 80 | Lee MN, Lee SY, Hur KY, Park HD. Thyroxine (T4) autoantibody interference of free T4 concentration measurement in a patient with Hashimoto’s thyroiditis. Ann Lab Med 2017;37:169-71. | 미소장 |
| 81 | Zouwail SA, O’Toole AM, Clark PM, Begley JP. Influence of thyroid hormone autoantibodies on 7 thyroid hormone assays. Clin Chem 2008;54:927-8. | 미소장 |
| 82 | Massart C, Elbadii S, Gibassier J, Coignard V, Rasandratana A. Anti-thyroxine and anti-triiodothyronine antibody interferences in one-step free triiodothyronine and free thyroxine immunoassays. Clin Chim Acta 2009;401:175-6. | 미소장 |
| 83 | Beato-Víbora PI and Alejo-González S. Avoiding misdiagnosis due to antibody interference with serum free thyroxin. Int J Endocrinol Metab 2016;15:e37792. | 미소장 |
| 84 | Srichomkwun P, Scherberg NH, Jakšić J, RefetoffS. Diagnostic dilemma in discordant thyroid function tests due to thyroid hormone autoantibodies. AACE Clin Case Rep 2017;3:e22-5. | 미소장 |
| 85 | van der Watt G, Haarburger D, Berman P. Euthyroid patient with elevated serum free thyroxine. Clin Chem 2008;54:1239-41. | 미소장 |
| 86 | Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, et al. Correlation of serum thyroid hormones autoantibodies with self-reported exposure to thyroid disruptors in a group of nonsegmental vitiligo patients. Arch Environ Contam Toxicol 2015;69:181-90. | 미소장 |
| 87 | Papo T, Oksenhendler E, Izembart M, Leger A, Clauvel JP. Antithyroid hormone antibodies induced by interferon-alpha. J Clin Endocrinol Metab 1992;75:1484-6. | 미소장 |
| 88 | Shimon I, Pariente C, Shlomo-David J, Grossman Z, Sack J. Transient elevation of triiodothyronine caused by triiodothyronine autoantibody associated with acute Epstein-Barr-virus infection. Thyroid 2003;13:211-5. | 미소장 |
| 89 | Henry JG, Sobki S, Arafat N. Interference by biotin therapy on measurement of TSH and FT4 by enzyme immunoassay on Boehringer Mannheim ES700 analyser. Ann Clin Biochem 1996;33:162-3. | 미소장 |
| 90 | Trambas C. Biotin interference in clinical laboratory tests: sporadic problem or a serious clinical issue? In: Dasgupta A and Sepulveda JL, eds. Accurate results in the clinical laboratory. 2nd ed. Amsterdam: Elsevier, 2019: 83-97. | 미소장 |
| 91 | Barbesino G. Misdiagnosis of Graves’ disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 2016;26:860-3. | 미소장 |
| 92 | Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves’ disease due to biotin immunoassay interference-A case and review of the literature. J Clin Endocrinol Metab 2016;101:3251-5. | 미소장 |
| 93 | U.S. Food and Drug Administration. UPDATE: the FDA warns that biotin may interfere with lab tests: FDA safety communication. https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication (Updated on 5 Nov 2019). | 미소장 |
| 94 | Piketty ML, Polak M, Flechtner I, Gonzales-Briceño L, Souberbielle JC. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med 2017;55:780-8. | 미소장 |
| 95 | Carter GD, Berry J, Cavalier E, Durazo-Arvizu R, Gunter E, Jones G, et al. Biotin supplementation causes erroneous elevations of results in some commercial serum 25-hydroxyvitamin D (25OHD) assays. J Steroid Biochem Mol Biol 2020;200:105639. | 미소장 |
| 96 | Plasse RA, Olson SW, Yuan CM, Nee R. Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis. Clin Kidney J 2020;13:710-2. | 미소장 |
| 97 | Stieglitz HM, Korpi-Steiner N, Katzman B, Mersereau JE, Styner M. Suspected testosterone-producing tumor in a patient taking biotin supplements. J Endocr Soc 2018;2:563-9. | 미소장 |
| 98 | Bizzarri C, Giannone GA, Gervasoni J, Benedetti S, Albanese F, Dello Strologo L, et al. Unusual presentation of a Denys–Drash syndrome girl with undisclosed assumption of biotin. J Clin Res Pediatr Endocrinol 2020 Aug 25. doi: 10.4274/jcrpe.galenos.2020.2020.0064. Online ahead of print. | 미소장 |
| 99 | Meany DL, Jan De Beur SM, Bill MJ, Sokoll LJ. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Clin Chem 2009;55:1737-9. | 미소장 |
| 100 | Koehler VF, Mann U, Nassour A, Mann WA. Fake news? Biotin interference in thyroid immunoassays. Clin Chim Acta 2018;484:320-2. | 미소장 |
| 101 | Ranaivosoa MK, Ganel S, Agin A, Romain S, Parent X, Reix N. Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases. Nephrol Ther 2017;13:553-8. | 미소장 |
| 102 | Feldt MM. Delayed diagnosis of congenital hypothyroidism in a child with trisomy 21 and biotinidase deficiency and successful use of levothyroxine sodium oral solution. Case Rep Endocrinol 2020;2020:8883969. | 미소장 |
| 103 | John JJ, Cooley V, Lipner SR. Assessment of biotin supplementation among patients in an outpatient dermatology clinic. J Am Acad Dermatol 2019;81:620-1. | 미소장 |
| 104 | Lipner SR. Update on biotin therapy in dermatology: time for a change. J Drugs Dermatol 2020;19:1264-5. | 미소장 |
| 105 | Soleymani T, Lo Sicco K, Shapiro J. The infatuation with biotin supplementation: is there truth behind its rising popularity? A Comparative analysis of clinical efficacy versus social popularity. J Drugs Dermatol 2017;16:496-500. | 미소장 |
| 106 | Pharmacovigilance Risk Assessment Committee. PRAC recommendations on signals. European Medicines Agency. https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommendations-signals-adopted-14-17-january-2019-prac-meeting_en.pdf (Updated on 11 Feb 2019). | 미소장 |
| 107 | Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem 2018;60:11-6. | 미소장 |
| 108 | Trambas CM, Liu KC, Luu H, Louey W, Lynch C, Yen T, et al. Further assessment of the prevalence of biotin supplementation and its impact on risk. Clin Biochem 2019;65:64-5. | 미소장 |
| 109 | Ijpelaar A, Beijers A, van Daal H, van den Ouweland JMW. Prevalence of detectable biotin in the Netherlands in relation to risk on immunoassay interference. Clin Biochem 2020;83:78-80. | 미소장 |
| 110 | Sanders A, Gama R, Ashby H, Mohammed P. Biotin immunoassay interference: a UK-based prevalence study. Ann Clin Biochem 2021;58:66-9. | 미소장 |
| 111 | Goldschmidt CH and Cohen JA. The rise and fall of high-dose biotin to treat progressive multiple sclerosis. Neurotherapeutics 2020;17:968-70. | 미소장 |
| 112 | Motte J and Gold R. High-dose biotin in multiple sclerosis: the end of the road. Lancet Neurol 2020;19:965-6. | 미소장 |
| 113 | Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, et al. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 2020;19:988-97. | 미소장 |
| 114 | Wolf B. High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: implications for individuals with biotin-responsive inherited metabolic disorders. Mol Genet Metab 2019;127:321-4. | 미소장 |
| 115 | Evans N, Yates J, Tobin J, McGill J, Huynh T. Immunoassay interference secondary to therapeutic high-dose biotin: A paediatric case report. J Paediatr Child Health 2018;54:572-5. | 미소장 |
| 116 | Bülow Pedersen I and Laurberg P. Biochemical hyperthyroidism in a newborn baby caused by assay interaction from biotin intake. Eur Thyroid J 2016;5:212-5. | 미소장 |
| 117 | Lefèvre CR, Peltier L, Damaj L, Valaize J, Bendavid C, Moreau C. Immunoassay disruption by high-dose biotin therapy: fair warning for neonatal care physicians. Pediatr Neurol 2020;112:8-9. | 미소장 |
| 118 | Avery G. Biotin interference in immunoassay: a review for the laboratory scientist. Ann Clin Biochem 2019;56:424-30. | 미소장 |
| 119 | Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves’ disease. N Engl J Med 2016;375:704-6. | 미소장 |
| 120 | Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 2017;55:817-25. | 미소장 |
| 121 | Biscolla RPM, Chiamolera MI, Kanashiro I, Maciel RMB, Vieira JGH. A single 10 mg oral dose of biotin interferes with thyroid function tests. Thyroid 2017;27:1099-100. | 미소장 |
| 122 | Zhang Y, Wang R, Dong Y, Huang G, Ji B, Wang Q. Assessment of biotin interference in thyroid function tests. Medicine (Baltimore) 2020;99:e19232. | 미소장 |
| 123 | Grimsey P, Frey N, Bendig G, Zitzler J, Lorenz O, Kasapic D, et al. Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference. Int J Pharmacokinet 2017;2:247-56. | 미소장 |
| 124 | Peyro Saint Paul L, Debruyne D, Bernard D, Mock DM, Defer GL. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol 2016;12:327-44. | 미소장 |
| 125 | Bowen R, Benavides R, Colón-Franco JM, Katzman BM, Muthukumar A, Sadrzadeh H, et al. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem 2019;74:1-11. | 미소장 |
| 126 | Gifford JL, de Koning L, Sadrzadeh SMH. Strategies for mitigating risk posed by biotin interference on clinical immunoassays. Clin Biochem 2019;65:61-3. | 미소장 |
| 127 | Mzougui S, Favresse J, Soleimani R, Fillée C, Gruson D. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing. Clin Chem Lab Med 2020;58:2037-45. | 미소장 |
| 128 | Lam L and Kyle CV. A simple method to detect biotin interference on immunoassays. Clin Chem Lab Med 2017;55:e104-6. | 미소장 |
| 129 | Trambas C, Lu Z, Yen T, Sikaris K. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays. Ann Clin Biochem 2018;55:216-26. | 미소장 |
| 130 | Moerman A and Delanghe JR. Sense and nonsense concerning biotin interference in laboratory tests. Acta Clin Belg 2020:1-7. | 미소장 |
| 131 | Rulander NJ, Cardamone D, Senior M, Snyder PJ, Master SR. Interference from anti-streptavidin antibody. Arch Pathol Lab Med 2013;137:1141-6. | 미소장 |
| 132 | Verougstraete N, Berth M, Vaneechoutte M, Delanghe J, Callewaert N. Interference of anti-streptavidin antibodies in immunoassays: A very rare phenomenon or a more common finding? Clin Chem Lab Med 2020;58:1673-80. | 미소장 |
| 133 | Dahll LK, Haave EM, Dahl SR, Aas FE, Thorsby PM. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated. Scand J Clin Lab Invest 2021;81:92-103. | 미소장 |
| 134 | Berth M, Willaert S, De Ridder C. Anti-streptavidin IgG antibody interference in anti-cyclic citrullinated peptide (CCP) IgG antibody assays is a rare but important cause of false-positive anti-CCP results. Clin Chem Lab Med 2018;56:1263-8. | 미소장 |
| 135 | Raverot V, Bordeau É, Periot C, Perrin P, Chardon L, Plotton I, et al. Letter to the editor: A case of laboratory-generated “thyroid dysfunction”. Ann Endocrinol (Paris) 2019;80:140-1. | 미소장 |
| 136 | Lam L, Bagg W, Smith G, Chiu WW, Middleditch MJ, Lim JC, et al. Apparent hyperthyroidism caused by biotin-like interference from IgM anti-streptavidin antibodies. Thyroid 2018;28:1063-7. | 미소장 |
| 137 | Peltier L, Massart C, Moineau MP, Delhostal A, Roudaut N. Anti-streptavidin interferences in Roche thyroid immunoassays: a case report. Clin Chem Lab Med 2016;54:e11-4. | 미소장 |
| 138 | Bayart JL, Favresse J, Melnik E, Lardinois B, Fillée C, Maiter D, et al. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clin Chem Lab Med 2019;57:e255-8. | 미소장 |
| 139 | Heijboer AC, Ijzerman RG, Bouman AA, Blankenstein MA. Two cases of antiruthenium antibody interference in Modular free thyroxine assay. Ann Clin Biochem 2009;46:263-4. | 미소장 |
| 140 | Buijs MM, Gorgels JP, Endert E. Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay. Ann Clin Biochem 2011;48:276-81. | 미소장 |
| 141 | Ando T, Yasui J, Inokuchi N, Usa T, Ashizawa K, Kamihara S, et al. Non-specific activities against ruthenium crosslinker as a new cause of assay interference in an electrochemilluminescent immunoassay. Intern Med 2007;46:1225-9. | 미소장 |
| 142 | Ohba K, Noh JY, Unno T, Satoh T, Iwahara K, Matsushita A, et al. Falsely elevated thyroid hormone levels caused by anti-ruthenium interference in the Elecsys assay resembling the syndrome of inappropriate secretion of thyrotropin. Endocr J 2012;59:663-7. | 미소장 |
| 143 | Zaninotto M, Tognon C, Venturini R, Betterle C, Plebani M. Interference in thyroid hormones with Roche immunoassays: an unfinished story. Clin Chem Lab Med 2014;52:e269-70. | 미소장 |
| 144 | Lim YY, Ong L, Loh TP, Sethi SK, Sng AAJ, Loke KY, et al. A diagnostic curiosity of isolated androstenedione elevation due to autoantibodies against horseradish peroxidase label of the immunoassay. Clin Chim Acta 2018;476:103-6. | 미소장 |
| 145 | Maharjan AS, Wyness SP, Ray JA, Willcox TL, Seiter JD, Genzen JR. Detection and characterization of estradiol (E2) and unconjugated estriol (uE3) immunoassay interference due to anti-bovine alkaline phosphatase (ALP) antibodies. Pract Lab Med 2019;17:e00131. | 미소장 |
| 146 | Sofronescu AG, Ross M, Rush E, Goldner W. Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa). Clin Biochem 2018;58:118-21. | 미소장 |
| 147 | U.S. Food and Drug Administration medical devices databases. Class 2 device recall ST AIAPACK ACTH (ACTH). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=169038 (updated on 14 Jan 2021). | 미소장 |
| 148 | Altawallbeh G and Karger AB. Letter to the Editor: assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure–A case series. J Endocr Soc 2019;4:bvz011. | 미소장 |
| 149 | Luzzi VI, Scott MG, Gronowski AM. Negative thyrotropin assay interference associated with an IgGkappa paraprotein. Clin Chem 2003;49:709-10. | 미소장 |
| 150 | Imperiali M, Jelmini P, Ferraro B, Keller F, della Bruna R, Balerna M, et al. Interference in thyroid-stimulating hormone determination. Eur J Clin Invest 2010;40:756-8. | 미소장 |
| 151 | Covinsky M, Laterza O, Pfeifer JD, Farkas-Szallasi T, Scott MG. An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem 2000;46:1157-61. | 미소장 |
| 152 | Whittle E, de Waal E, Huynh T, Treacy O, Morton A. Pre-analytical mysteries: A case of severe hypervitaminosis D and mild hypercalcaemia. Biochem Med (Zagreb) 2021;31:011001. | 미소장 |
| 153 | Ismail AA. Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know. J Clin Pathol 2009;62:673-8. | 미소장 |
| 154 | Hager HB, Bolstad N, Warren DJ, Ness MV, Seierstad B, Lindberg M. Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies. Clin Chem Lab Med 2021;59:663-9. | 미소장 |
| 155 | Ong MW, Salota R, Reeman T, Lapsley M, Jones L. Artefactual 25-OH vitamin D concentration in multiple myeloma. Ann Clin Biochem 2017;54:716-20. | 미소장 |
| 156 | Visser WE and Peeters RP. Interpretation of thyroid function tests during pregnancy. Best Pract Res Clin Endocrinol Metab 2020;34:101431. | 미소장 |
| 157 | Khoo S, Lyons G, McGowan A, Gurnell M, Oddy S, Visser WE, et al. Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods. Eur J Endocrinol 2020;182:533-8. | 미소장 |
| 158 | Cartwright D, O’Shea P, Rajanayagam O, Agostini M, Barker P, Moran C, et al. Familial dysalbuminemic hyperthyroxinemia: A persistent diagnostic challenge. Clin Chem 2009;55:1044-6. | 미소장 |
| 159 | Ross HA, de Rijke YB, Sweep FC. Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia. Clin Chem 2011;57:524-5. | 미소장 |
| 160 | Kragh-Hansen U, Galliano M, Minchiotti L. Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia. Front Endocrinol (Lausanne) 2017;8:297. | 미소장 |
| 161 | DeCosimo DR, Fang SL, Braverman LE. Prevalence of familial dysalbuminemic hyperthyroxinemia in Hispanics. Ann Intern Med 1987;107:780-1. | 미소장 |
| 162 | Pappa T, Ferrara AM, RefetoffS. Inherited defects of thyroxine-binding proteins. Best Pract Res Clin Endocrinol Metab 2015;29:735-47. | 미소장 |
| 163 | Campi I, Covelli D, Moran C, Fugazzola L, Cacciatore C, Orlandi F, et al. The differential diagnosis of discrepant thyroid function tests: insistent pitfalls and updated flow-chart based on a long-standing experience. Front Endocrinol (Lausanne) 2020;11:432. | 미소장 |
| 164 | Dieu X, Bouzamondo N, Briet C, Illouz F, Moal V, Boux de Casson F, et al. Familial dysalbuminemic hyperthyroxinemia: an underdiagnosed entity. J Clin Med 2020;9:2105. | 미소장 |
| 165 | Rosner W, Auchus RJ, Azziz R, Sluss PM, RaffH. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-13. | 미소장 |
| 166 | Keevil BG and Adaway J. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol 2019;190:207-11. | 미소장 |
| 167 | Faye SA, Groome N, Masica R, Kertez G. Investigation and resolution of the effect of an interfering factor in the Beckman Coulter anti-Müllerian hormone (AMH) Gen II ELISA assay. Hum Reprod 2014;29:331. | 미소장 |
| 168 | Turner KA, Larson BJ, Kreofsky NC, Willrich MAV, Bornhorst JA, Algeciras-Schimnich A. Assessment of complement interference in anti-Müllerian hormone immunoassays. Clin Chem Lab Med 2020;58:e8-10. | 미소장 |
| 169 | Monaghan PJ, Kyriacou A, Sturgeon C, Davies A, Trainer PJ, White A, et al. Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study. Clin Endocrinol (Oxf) 2016;85:569-74. | 미소장 |
| 170 | Lauro C, CorcuffJ-B, Brossaud J, Georges A. What to do in the event of a suspicion of analytical interference during an immunoassay? Ann Biol Clin (Paris) 2020;78:70-3. | 미소장 |
| 171 | Gurnell M, Halsall DJ, Chatterjee VK. What should be done when thyroid function tests do not make sense? Clin Endocrinol (Oxf) 2011;74:673-8. | 미소장 |
| 172 | Cavalier E, Carlisi A, Chapelle JP, Delanaye P. False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin Chim Acta 2008;387:150-2. | 미소장 |
| 173 | Ellis MJ and Livesey JH. Techniques for identifying heterophile antibody interference are assay specific: study of seven analytes on two automated immunoassay analyzers. Clin Chem 2005;51:639-41. | 미소장 |
| 174 | Choy KW, Teng J, Wijeratne N, Tan CY, Doery JC. Immunoassay interference complicating management of Cushing’s disease: the onus is on the clinician and the laboratory. Ann Clin Biochem 2017;54:183-4. | 미소장 |
| 175 | Faix JD. Principles and pitfalls of free hormone measurements. Best Pract Res Clin Endocrinol Metab 2013;27:631-45. | 미소장 |
| 176 | Ismail AA. On detecting interference from endogenous antibodies in immunoassays by doubling dilutions test. Clin Chem Lab Med 2007;45:851-4. | 미소장 |
| 177 | Cole LA and Khanlian SA. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total β-hCG test. Clin Biochem 2004;37:344-9. | 미소장 |
| 178 | Santhana Krishnan SG, Pathalapati R, Kaplan L, Cobbs RK. Falsely raised TSH levels due to human anti‐mouse antibody interfering with thyrotropin assay. Postgrad Med J 2006;82:e27. | 미소장 |
| 179 | Interlaboratory survey of methods for measuring human anti-mouse antibodies. HAMA Survey Group. Clin Chem 1992;38:172-3. | 미소장 |
| 180 | Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, Gruson D. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med 2018;56:e160-3. | 미소장 |
| 181 | Giovanella L, Giordani I, Imperiali M, Orlandi F, Trimboli P. Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia. Clin Chem Lab Med 2018;56:e191-3. | 미소장 |
| 182 | Wong T, Shackleton CH, Covey TR, Ellis G. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clin Chem 1992;38:1830-7. | 미소장 |
| 183 | Makela SK and Ellis G. Nonspecificity of a direct 17 alpha-hydroxyprogesterone radioimmunoassay kit when used with samples from neonates. Clin Chem 1988;34:2070-5. | 미소장 |
| 184 | Hawley JM, Owen LJ, Lockhart SJ, Monaghan PJ, Armston A, Chadwick CA, et al. Serum cortisol: an up-to-date assessment of routine assay performance. Clin Chem 2016;62:1220-9. | 미소장 |
| 185 | Vogeser M, Kratzsch J, Ju Bae Y, Bruegel M, Ceglarek U, Fiers T, et al. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med 2017;55:826-35. | 미소장 |
| 186 | Thomas CM, van den Berg RJ, Segers MF, Bartelink ML, Thien T. Inaccurate measurement of 17 beta-estradiol in serum of female volunteers after oral administration of milligram amounts of micronized 17 beta-estradiol. Clin Chem 1993;39:2341-2. | 미소장 |
| 187 | Nahoul K, Dehennin L, Scholler R. Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. J Steroid Biochem 1987;26:241-9. | 미소장 |
| 188 | Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49:1381-95. | 미소장 |
| 189 | Warner MH, Kane JW, Atkin SL, Kilpatrick ES. Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Ann Clin Biochem 2006;43:196-9. | 미소장 |
| 190 | Piketty ML, d’Herbomez M, Le Guillouzic D, Lebtahi R, Cosson E, Dumont A, et al. Clinical comparison of three labeled-antibody immunoassays of free triiodothyronine. Clin Chem 1996;42:933-41. | 미소장 |
| 191 | Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol 2014;14:33. | 미소장 |
| 192 | Dias ML, Vieira JG, Abucham J. Detecting and solving the interference of pregnancy serum, in a GH immunometric assay. Growth Horm IGF Res 2013;23:13-8. | 미소장 |
| 193 | Schiettecatte J, Strasser O, Anckaert E, Smitz J. Performance evaluation of an automated electrochemiluminescent calcitonin (CT) immunoassay in diagnosis of medullary thyroid carcinoma. Clin Biochem 2016;49:929-31. | 미소장 |
| 194 | Hillebrand JJ, Siegelaar SE, Heijboer AC. Falsely decreased thyroglobulin levels in a patient with differentiated thyroid carcinoma. Clin Chim Acta 2020;509:217-9. | 미소장 |
| 195 | Cormano J, Mackay G, Holschneider C. Gestational trophoblastic disease diagnosis delayed by the hook effect. Obstet Gynecol 2015;126:811-4. | 미소장 |
| 196 | Pillay TS, Muyldermans S. Application of single domain antibodies (“nanobodies”) to laboratory diagnosis. Ann Lab Med 2021;41:549-58. | 미소장 |
MARC 보기
오류 데이터 정정요청
*표시는 필수 입력사항입니다.
알림톡 발송
| *전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
|---|
연속간행물 권호 선택
우편복사 안내
- ◾ 도서관을 방문하지 못할 경우 인터넷, 팩스 등으로 자료 복사를 신청하고, 복사물을 우편·팩스 등으로 제공받는 서비스
- ◾ 대상자료: 일반도서, 연속간행물 및 학위논문
- ※ 고서, 고잡지, 훼손될 우려가 있는 자료, 마이크로폼 자료 및 신문 등 제외
- ◾ 신청 책수: 1인 5책 이하(1일 기준)
- ◾ 신청 절차: 자료 검색 → 우편복사 목록담기 → 복사 범위 입력 → 우편복사 주문서 입력 → 접수 및 확인
- ※ 저작권법에 의거하여 부분 복사(전체 페이지 수의 1/3 범위 이내)만 가능
- ◾ 복사 범위 입력 예시: (연속 페이지) 1-30, (부분 페이지) 25, 30-40
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내(서울관)
도서위치안내: 정기간행물실(524호) / 서가번호: 국내16
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
0
확인
우편복사 목록담기를 완료하였습니다.
내서재에 담기
새로운 서재
*표시는 필수 입력사항입니다.
저장
저장 되었습니다.